Circulating tumor cells allow researchers to detect cancer early, provide an accurate prognosis, monitor progression, and ...

For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI ...

According to Precedence Research, the global liquid biopsy market size will grow from USD 7.05 billion in 2025 to nearly USD ...

Is our health system ready for multi-cancer detection tests? That was the question Fred Hutch's Dr. Scott Ramsey and others posed at a full-day Cancer Screening Intelligence for the Future symposium ...

A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...

Bispecific Antibodies in Hematologic and Solid Tumors: Current Landscape and Therapeutic Advances Liquid biopsy encompasses a variety of molecular approaches to detect circulating tumor DNA (ctDNA) ...

Researchers are studying tests called liquid biopsies, which can provide vital information about cancer genes using only a blood sample. A blood test to find cancer even before it shows any symptoms ...

In a pair of studies, investigators from the lab of Huiping Liu, MD, Ph.D., associate professor of Pharmacology and of ...

Circulating tumor cells (CTCs) are malignant cells that have detached from primary or metastatic tumor sites and entered the peripheral bloodstream. As a critical component of liquid biopsy, the ...

Small cell lung cancer cells that metastasize to the brain cozy up to neurons and form working electrical connections, called synapses, according to a study led by Stanford Medicine researchers. The ...